Publications

(2025). Marginal and conditional summary measures: transportability and compatibility across studies.
(2025). Population-Adjusted Indirect Comparisons. In R for Health Technology Assessment.
(2025). The Importance of Specifying the Estimand in Meta-Analyses in the Presence of Treatment Switching. In Value in Health, 28(6).
(2025). Effect modification and non-collapsibility together may lead to conflicting treatment decisions: A review of marginal and conditional estimands and recommendations for decision-making. Research Synthesis Methods, 16(2).
(2024). Treatment Switching in Evidence Synthesis in Oncology: A Comprehensive Review of Current Meta-Analytical Practices. In Value in Health, 27(12).
(2024). Estimands and their implications for evidence synthesis for oncology: A case study of treatment switching in meta-analysis.
(2024). The ICH E9 (R1) Estimand Framework in the Context of Real-World Data and Observational Studies. In Pharmacoepidemiology and Drug Safety, 33(1).
(2024). Transportability of model-based estimands in evidence synthesis. Statistics in Medicine, 43(22).
(2024). Broad versus narrow research questions in evidence synthesis: A parallel to (and plea for) estimands. Research Synthesis Methods, 15(5).